4.7 Article

A Quantitative Digital Analysis of Tissue Immune Components Reveals an Immunosuppressive and Anergic Immune Response with Relevant Prognostic Significance in Glioblastoma

Related references

Note: Only part of the references are listed.
Review Oncology

Signal Pathways Involved in the Interaction Between Tumor-Associated Macrophages/TAMs and Glioblastoma Cells

Xiaojin Liu et al.

Summary: Glioblastoma is a complex tumor comprised of neoplastic and non-neoplastic cells, with tumor-associated macrophages playing crucial roles in tumor progression. The interactions between tumor cells and TAMs result in an immunosuppressive and tumor-supportive microenvironment. Understanding these interactions can lead to potential therapeutic targets for glioblastoma.

FRONTIERS IN ONCOLOGY (2022)

Article Medicine, Research & Experimental

Arginine deprivation alters microglial polarity and synergizes with radiation to eradicate non-arginine-auxotrophic glioblastoma tumors

Nabil Hajji et al.

Summary: The study suggests that ADI-PEG20, an arginine-depleting agent, can potentiate the efficacy of radiotherapy in glioblastoma, leading to improved treatment outcomes without significant toxicity. Furthermore, ADI-PEG20 also promotes an anti-tumor immune response. This study provides a promising strategy for GBM treatment that should be further evaluated in clinical trials.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Review Neurosciences

Macrophages and microglia: the cerberus of glioblastoma

Alice Buonfiglioli et al.

Summary: GBM is a highly aggressive and lethal primary brain tumor, characterized by malignant growth, invasion into brain parenchyma, and resistance to therapy. The GBM microenvironment consists of neoplastic and non-neoplastic cells, with tumor-associated macrophages (TAMs) being the most abundant non-neoplastic cells. TAMs play essential roles in promoting tumor progression by interacting with tumor cells and other non-neoplastic cells in the tumor microenvironment.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Targeting of CD163+Macrophages in Inflammatory and Malignant Diseases

Maria K. Skytthe et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Biochemistry & Molecular Biology

Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma

Kurt A. Schalper et al.

NATURE MEDICINE (2019)

Article Neurosciences

Immune landscapes associated with different glioblastoma molecular subtypes

Maria Martinez-Lage et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2019)

Article Clinical Neurology

Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas

Pia S. Zeiner et al.

BRAIN PATHOLOGY (2019)

Review Medicine, Research & Experimental

CD8 T Cell Exhaustion in Chronic Infection and Cancer: Opportunities for Interventions

Masao Hashimoto et al.

ANNUAL REVIEW OF MEDICINE, VOL 69 (2018)

Article Oncology

T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma

Karolina Woroniecka et al.

CLINICAL CANCER RESEARCH (2018)

Article Multidisciplinary Sciences

Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment

Elisa Peranzoni et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article

T-cell exhaustion in glioblastoma

Karolina Woroniecka et al.

Oncotarget (2018)

Article Medicine, Research & Experimental

Imbalance of immunological synapse-kinapse states reflects tumor escape to immunity in glioblastoma

Laura R. Diaz et al.

JCI INSIGHT (2018)

Review Cell Biology

Colour in digital pathology: a review

Emily L. Clarke et al.

HISTOPATHOLOGY (2017)

Article Clinical Neurology

Microglia and brain macrophages: An update

Atsushi Sasaki

NEUROPATHOLOGY (2017)

Article Oncology

PD-L1 expression and prognostic impact in glioblastoma

Edjah K. Nduom et al.

NEURO-ONCOLOGY (2016)

Article Pathology

Digital image analysis outperforms manual biomarker assessment in breast cancer

Gustav Stalhammar et al.

MODERN PATHOLOGY (2016)

Review Pathology

Molecular and Genomic Alterations in Glioblastoma Multiforme

Ines Crespo et al.

AMERICAN JOURNAL OF PATHOLOGY (2015)

Review Biotechnology & Applied Microbiology

Applications and challenges of digital pathology and whole slide imaging

C. Higgins

BIOTECHNIC & HISTOCHEMISTRY (2015)

Review Clinical Neurology

Prospects of immune checkpoint modulators in the treatment of glioblastoma

Matthias Preusser et al.

NATURE REVIEWS NEUROLOGY (2015)

Article Neurosciences

Alternatively activated microglia and macrophages in the central nervous system

Rafael Franco et al.

PROGRESS IN NEUROBIOLOGY (2015)

Review Oncology

Clinical significance of macrophage heterogeneity in human malignant tumors

Yoshihiro Komohara et al.

CANCER SCIENCE (2014)

Article Biochemistry & Molecular Biology

CSF-1R inhibition alters macrophage polarization and blocks glioma progression

Stephanie M. Pyonteck et al.

NATURE MEDICINE (2013)

Article Oncology

Immune Heterogeneity of Glioblastoma Subtypes: Extrapolation from the Cancer Genome Atlas

Tiffany Doucette et al.

CANCER IMMUNOLOGY RESEARCH (2013)

Review Oncology

Tumor-Associated Macrophages in Glioma: Friend or Foe?

Benjamin C. Kennedy et al.

JOURNAL OF ONCOLOGY (2013)

Article Clinical Neurology

CD8+T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival

Isaac Yang et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2010)

Article Oncology

Incidence and prognostic impact of FoxP3+ regulatory T cells in human gliomas

Amy B. Heimberger et al.

CLINICAL CANCER RESEARCH (2008)

Article Cell Biology

AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype

Yoshihiro Komohara et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2006)